Reply to C.-H. Chang et al.
Yoshiko Urata, Hyogo Cancer Center, Hyogo, Japan.
Yoshiko
Y
Urata
D000077192:Adenocarcinoma of Lung; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans
D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib